Dipannita Basu

Bootstrap capitalism and the culture industries: a critique of invidious comparisons in the study of ethnic entrepreneurship

Dipannita Basu, Pnina Werbner · Ethnic and Racial Studies · 2001 · 74 citations

Social Sciences, Entrepreneurship, Sociology +15

PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: Implications for the treatment of negative symptoms in schizophrenia

Bailee A. Dyck, Kelly A. Guest, Christal D. Sookram et al. · Schizophrenia Research · 2010 · 31 citations

Medicine, Neuroscience, Pharmacology +16

Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs

Mattea Tan, Bailee A. Dyck, Joseph Gabriele et al. · The Pharmacogenomics Journal · 2013 · 27 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: Evidence for the allosteric modulation of the dopamine receptor

Amandeep Mann, Vaneeta Verma, Dipannita Basu et al. · European Journal of Pharmacology · 2010 · 19 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia

Mattea Tan, Dipannita Basu, Jacek M. Kwiecień et al. · Peptides · 2013 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +13